From Nasdaq: 2024-05-19 08:59:16

In a comparison between DexCom (DXCM) and 3M (MMM) stocks with a similar market capitalization, DXCM stands out with a higher valuation multiple of 13x versus 1.7x for MMM due to its superior revenue growth, profitability, and financial position. Recently, DXCM stock has outperformed MMM, which has seen declines. DexCom’s revenue growth of 23% annually over the past three years far exceeds 3M’s 1% growth. The company’s profitability and financial risk position are also stronger than 3M’s, making DXCM a better bet for investors. Despite challenges faced by both companies in the past, DexCom’s growth potential and customer base expansion appear promising, leading to favorable prospects for the stock compared to 3M.



Read more at Nasdaq: Will DexCom Offer Better Returns Than 3M Stock?